Kaplowitz N - Search Results

1

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC. Watkins PB, et al. Among authors: kaplowitz n. JAMA. 2006 Jul 5;296(1):87-93. doi: 10.1001/jama.296.1.87. JAMA. 2006. PMID: 16820551 Clinical Trial.

2

Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database.

Watkins PB, Lewis JH, Kaplowitz N, Alpers DH, Blais JD, Smotzer DM, Krasa H, Ouyang J, Torres VE, Czerwiec FS, Zimmer CA. Watkins PB, et al. Among authors: kaplowitz n. Drug Saf. 2015 Nov;38(11):1103-13. doi: 10.1007/s40264-015-0327-3. Drug Saf. 2015. PMID: 26188764 Free PMC article.

3

Drug-induced liver injury.

Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Andrade RJ, et al. Among authors: kaplowitz n. Nat Rev Dis Primers. 2019 Aug 22;5(1):58. doi: 10.1038/s41572-019-0105-0. Nat Rev Dis Primers. 2019. PMID: 31439850 Free article. Review.

4

The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future.

Watkins PB, Merz M, Avigan MI, Kaplowitz N, Regev A, Senior JR. Watkins PB, et al. Among authors: kaplowitz n. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S1-7. doi: 10.1007/s40264-014-0181-8. Drug Saf. 2014. PMID: 25352323 Free PMC article. No abstract available.

5

Did this drug cause my patient's hepatitis?

Kaplowitz N, Lewis JH, Watkins PB. Kaplowitz N, et al. Ann Intern Med. 2003 Jan 21;138(2):159-60; author reply 159-60. doi: 10.7326/0003-4819-138-2-200301210-00025. Ann Intern Med. 2003. PMID: 12529106 No abstract available.

6

Liver safety assessment in special populations (hepatitis B, C, and oncology trials).

Kullak-Ublick GA, Merz M, Griffel L, Kaplowitz N, Watkins PB. Kullak-Ublick GA, et al. Among authors: kaplowitz n. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S57-62. doi: 10.1007/s40264-014-0186-3. Drug Saf. 2014. PMID: 25352328 Free PMC article. Review.

7

Case definition and phenotype standardization in drug-induced liver injury.

Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Aithal GP, et al. Among authors: kaplowitz n. Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4. Clin Pharmacol Ther. 2011. PMID: 21544079 Review.

8

Current challenges and controversies in drug-induced liver injury.

Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M. Corsini A, et al. Among authors: kaplowitz n. Drug Saf. 2012 Dec 1;35(12):1099-117. doi: 10.1007/BF03261997. Drug Saf. 2012. PMID: 23137150

9

c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity.

Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N. Gunawan BK, et al. Among authors: kaplowitz n. Gastroenterology. 2006 Jul;131(1):165-78. doi: 10.1053/j.gastro.2006.03.045. Gastroenterology. 2006. PMID: 16831600

10

Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity.

Liu ZX, Govindarajan S, Kaplowitz N. Liu ZX, et al. Among authors: kaplowitz n. Gastroenterology. 2004 Dec;127(6):1760-74. doi: 10.1053/j.gastro.2004.08.053. Gastroenterology. 2004. PMID: 15578514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters